Cellvie Company

cellvie is pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism. The technology's first application will be in ischemia-reperfusion injury, specifically in kidney transplantation. But the aim is to develop a broad platform.

Last Funding Type: Seed
Headquarters: Matzingen / Switzerland
Founded Date: 2018
Investor Type: Seed
Last Funding Date: 2021
Total Funding: 5000000
Employee Number: 1-10
Investors Number: 1
Industry: PharmTech